The Real World Study of the Clnical Efficacy of Huaier Granule for Asthma Therapy

The Real World Study of Huaier Granule for Asthma Therapy

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-16010009

Enrollment

Unknown

Registered

2016-11-24

Start date

2016-01-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

routine therapy:inhale corticosteroids

Experimental:Huaier Granule

Eligibility

Sex/Gender

All

Age

2 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1. The patients have a more than six months course of asthma; 2. Patients aged 2-5 years old girl and boy; 3. The legal guardians of the patients must sign an informed censent.

Exclusion criteria

Exclusion criteria: 1. Patients with a state of acute exacerbation; 2. Patients with serious diseases such as cardiovascular diseases, liver diseases, kidney dieases, hematological system diseases; 3. Patients have participated other clinical trials of drugs.

Design outcomes

Primary

Measure	Time frame
frequence of asthma episodes;severity of asthma episodes;persistence of asthma episodes;frequece of severe asthma attack;	—

Secondary

Measure	Time frame
times of respiratrory infection during observation;	—

Countries

China

Contacts

Public ContactChuanhe Liu

Capital Institute of Pediatrics

liuchcip@126.com+86 010-85695568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026